Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Alize Pharma raises funds to advance AZP-531

June 7, 2012

Long-term study of Contrave begins enrollment

June 7, 2012

U.S. team presents new products for cancer and other disorders

June 7, 2012

Phase III elagolix study begins in endometriosis

June 6, 2012

CHMP schedules hearing for Vivus' Qnexa MAA

June 6, 2012

Janssen files NDA for canagliflozin

June 5, 2012

Takeda expands its position in gout market

June 5, 2012

Mitsubishi Tanabe terminates license agreement

June 4, 2012

Roche group identifies new cathepsin inhibitors

June 4, 2012

U.S. team patents new DAP kinase 1 inhibitors and PPAR-gamma/GPR120 partial agonists

June 1, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...